Tudor Investment Corp’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-33,595
| Closed | -$1.96M | – | 3638 |
|
|
2025
Q4 | $1.81M | Sell |
33,595
-1,166,198
| -97% | -$56.1M | ﹤0.01% | 1880 |
|
|
2025
Q3 | $54.1M | Buy |
+1,199,793
| New | +$56M | 0.09% | 161 |
|
|
2025
Q1 | – | Sell |
-10,960
| Closed | -$639K | – | 3077 |
|
|
2024
Q4 | $620K | Buy |
+10,960
| New | +$612K | ﹤0.01% | 2068 |
|
|
2024
Q3 | – | Sell |
-2,000,813
| Closed | -$93.9M | – | 2719 |
|
|
2024
Q2 | $83.1M | Buy |
+2,000,813
| New | +$89.5M | 0.43% | 8 |
|
|
2024
Q1 | – | Sell |
-767,451
| Closed | -$39.1M | – | 2244 |
|
|
2023
Q4 | $39.4M | Buy |
+767,451
| New | +$40.3M | 0.32% | 22 |
|
|
2023
Q3 | – | Sell |
-27,490
| Closed | -$1.68M | – | 2297 |
|
|
2023
Q2 | $1.76M | Buy |
27,490
+16,254
| +145% | +$1.09M | 0.02% | 965 |
|
|
2023
Q1 | $779K | Sell |
11,236
-266,633
| -96% | -$18.8M | 0.01% | 1354 |
|
|
2022
Q4 | $20M | Buy |
277,869
+267,151
| +2,493% | +$20.1M | 0.4% | 16 |
|
|
2022
Q3 | $4.95M | Sell |
10,718
-4,150
| -28% | -$301K | 0.11% | 224 |
|
|
2022
Q2 | $4.88M | Buy |
+14,868
| New | +$1.13M | 0.13% | 185 |
|
|
2022
Q1 | – | Sell |
-8,809
| Closed | -$591K | – | 2034 |
|
|
2021
Q4 | $549K | Sell |
8,809
-186,135
| -95% | -$10.9M | 0.01% | 1393 |
|
|
2021
Q3 | $11.5M | Buy |
+194,944
| New | +$12.8M | 0.19% | 74 |
|
|
2021
Q2 | – | Sell |
-58,232
| Closed | -$3.68M | – | 1615 |
|
|
2021
Q1 | $3.68M | Sell |
58,232
-40,784
| -41% | -$2.54M | 0.07% | 280 |
|
|
2020
Q4 | $6.14M | Buy |
+99,016
| New | +$6.09M | 0.17% | 92 |
|
|
2019
Q3 | – | Sell |
-89,020
| Closed | -$4.18M | – | 1095 |
|
|
2019
Q2 | $4.04M | Sell |
89,020
-171,836
| -66% | -$8M | 0.12% | 131 |
|
|
2019
Q1 | $12.4M | Buy |
260,856
+201,011
| +336% | +$10M | 0.51% | 22 |
|
|
2018
Q4 | $3.11M | Sell |
59,845
-81,904
| -58% | -$4.4M | 0.06% | 112 |
|
|
2018
Q3 | $8.8M | Buy |
141,749
+55,031
| +63% | +$3.27M | 0.22% | 54 |
|
|
2018
Q2 | $4.8M | Buy |
86,718
+18,143
| +26% | +$980K | 0.17% | 80 |
|
|
2018
Q1 | $4.34M | Buy |
68,575
+38,789
| +130% | +$2.5M | 0.14% | 57 |
|
|
2017
Q4 | $1.82M | Sell |
29,786
-95,178
| -76% | -$5.95M | 0.05% | 191 |
|
|
2017
Q3 | $7.96M | Buy |
124,964
+42,578
| +52% | +$2.49M | 0.2% | 53 |
|
|
2017
Q2 | $4.59M | Buy |
82,386
+60,685
| +280% | +$3.3M | 0.14% | 96 |
|
|
2017
Q1 | $1.18M | Sell |
21,701
-2,076
| -9% | -$114K | 0.04% | 319 |
|
|
2016
Q4 | $1.39M | Sell |
23,777
-93,110
| -80% | -$5.09M | 0.04% | 250 |
|
|
2016
Q3 | $6.3M | Buy |
116,887
+103,087
| +747% | +$6.62M | 0.15% | 98 |
|
|
2016
Q2 | $1.01M | Buy |
13,800
+2,000
| +17% | +$141K | 0.02% | 448 |
|
|
2016
Q1 | $754K | Buy |
11,800
+1,400
| +13% | +$88.3K | 0.02% | 690 |
|
|
2015
Q4 | $715K | Sell |
10,400
-5,920
| -36% | -$391K | 0.02% | 649 |
|
|
2015
Q3 | $966K | Sell |
16,320
-9,551
| -37% | -$606K | 0.03% | 398 |
|
|
2015
Q2 | $1.72M | Sell |
25,871
-138,644
| -84% | -$9.14M | 0.05% | 239 |
|
|
2015
Q1 | $10.6M | Buy |
+164,515
| New | +$10.3M | 0.34% | 46 |
|
|
2014
Q4 | – | Sell |
-14,869
| Closed | -$761K | – | 1455 |
|
|
2014
Q3 | $761K | Sell |
14,869
-19,843
| -57% | -$991K | 0.03% | 427 |
|
|
2014
Q2 | $1.68M | Buy |
34,712
+18,363
| +112% | +$905K | 0.06% | 121 |
|
|
2014
Q1 | $849K | Sell |
16,349
-83,651
| -84% | -$4.45M | 0.04% | 261 |
|
|
2013
Q4 | $5.32M | Sell |
100,000
-125,000
| -56% | -$6.37M | 0.26% | 65 |
|
|
2013
Q3 | $10.4M | Buy |
+225,000
| New | +$9.88M | 0.43% | 43 |
|
Other funds holding BMY
VCM
VPM
Tudor Investment Corp's BMY Position: Q1 2026 in Review
Tudor Investment Corp sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 33,595 shares — an estimated $1.96M sold.
Tudor Investment Corp first reported a position in BMY in Q3 2013 and held it in 37 quarters. The position peaked at $83.1M in Q2 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Tudor Investment Corp reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Tudor Investment Corp sold 33,595 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.96M.
- Tudor Investment Corp first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 37 quarters.
- Tudor Investment Corp's Bristol-Myers Squibb position peaked at $83.1M in Q2 2024.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.